Cargando…

CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy

Detalles Bibliográficos
Autores principales: Wang, Hong-Juan, Ma, Cong, Yang, Jie, Xu, Qiang, Zhang, Yan, Gao, Lei, Xu, Bin, Zhang, Yu-Xiao, Li, Yang, Yin, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418912/
https://www.ncbi.nlm.nih.gov/pubmed/23097648
http://dx.doi.org/10.3724/SP.J.1263.2012.04162
_version_ 1782240670541414400
author Wang, Hong-Juan
Ma, Cong
Yang, Jie
Xu, Qiang
Zhang, Yan
Gao, Lei
Xu, Bin
Zhang, Yu-Xiao
Li, Yang
Yin, Tong
author_facet Wang, Hong-Juan
Ma, Cong
Yang, Jie
Xu, Qiang
Zhang, Yan
Gao, Lei
Xu, Bin
Zhang, Yu-Xiao
Li, Yang
Yin, Tong
author_sort Wang, Hong-Juan
collection PubMed
description
format Online
Article
Text
id pubmed-3418912
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Science Press
record_format MEDLINE/PubMed
spelling pubmed-34189122012-10-24 CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy Wang, Hong-Juan Ma, Cong Yang, Jie Xu, Qiang Zhang, Yan Gao, Lei Xu, Bin Zhang, Yu-Xiao Li, Yang Yin, Tong J Geriatr Cardiol Letters to the Editor Science Press 2012-06 /pmc/articles/PMC3418912/ /pubmed/23097648 http://dx.doi.org/10.3724/SP.J.1263.2012.04162 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Letters to the Editor
Wang, Hong-Juan
Ma, Cong
Yang, Jie
Xu, Qiang
Zhang, Yan
Gao, Lei
Xu, Bin
Zhang, Yu-Xiao
Li, Yang
Yin, Tong
CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
title CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
title_full CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
title_fullStr CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
title_full_unstemmed CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
title_short CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
title_sort cyp4f2 polymorphism as a genetic risk factor for major hemorrhagic complications in chinese patients on warfarin therapy
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418912/
https://www.ncbi.nlm.nih.gov/pubmed/23097648
http://dx.doi.org/10.3724/SP.J.1263.2012.04162
work_keys_str_mv AT wanghongjuan cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT macong cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT yangjie cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT xuqiang cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT zhangyan cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT gaolei cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT xubin cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT zhangyuxiao cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT liyang cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy
AT yintong cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy